Search results
Results from the WOW.Com Content Network
The rehabilitation process following a spinal cord injury typically begins in the acute care setting. Occupational therapy plays an important role in the management of SCI. [2] Recent studies emphasize the importance of early occupational therapy, started immediately after the client is stable.
To save a patient in respiratory arrest, the goal is to restore adequate ventilation and prevent further damage. Management interventions include supplying oxygen, opening the airway, and means of artificial ventilation. In some instances, an impending respiratory arrest could be predetermined by signs the patient is showing, such as the ...
Spinal cord injury patients often require extended treatment in specialized spinal unit or an intensive care unit. [118] The rehabilitation process typically begins in the acute care setting. Usually, the inpatient phase lasts 8–12 weeks and then the outpatient rehabilitation phase lasts 3–12 months after that, followed by yearly medical ...
As an outcome measure specifically designed for spinal cord injury, the Spinal Cord Independence Measure is a tool that evaluates how safely, cheaply, and independently a patient can do basic activities of daily living.
Spinal cord compression is a form of myelopathy in which the spinal cord is compressed. Causes can be bone fragments from a vertebral fracture, a tumor , abscess , ruptured intervertebral disc or other lesion.
Before the widespread use of spinal precautions in the 1970s, 55% of patients referred to spinal cord injury centers had complete spinal cord injury. [12] In the 1980s, spinal immobilization was initially used routinely for people who had experienced physical trauma, with little evidence to support its use. [ 21 ]
Spinal cord injury research seeks new ways to cure or treat spinal cord injury in order to lessen the debilitating effects of the injury in the short or long term. There is no cure for SCI, and current treatments are mostly focused on spinal cord injury rehabilitation and management of the secondary effects of the condition. [ 1 ]
The trial aimed to evaluate the drug GRNOPC1, embryonic stem cell-derived oligodendrocyte progenitor cells, on people with acute spinal cord injury. The trial was discontinued in November 2011 so that the company could focus on therapies in the "current environment of capital scarcity and uncertain economic conditions". [25]